Best Hydrafacial in Warwick Rhode Island and Fall River Massachusetts

What is Hydrafacial?

HydraFacial is the only hydradermabrasion procedure that combines cleansing, exfoliation, extraction, hydration and antioxidant protection simultaneously, resulting in clearer, more beautiful skin with no discomfort or downtime. The treatment is soothing, moisturizing, non-invasive and non-irritating.

Skin Health for Life™ is not just improving your appearance, but actually restoring youthful, healthy skin. Skin Health is a lifestyle, requiring monthly maintenance and the right treatment for every skin type. The treatment is the HydraFacial™ by Agape Medical Spa and Skin Care in Rhode Island.

The Best HydraFacial™ treatment in Warwick, Rhode Island merges soothing and invigorating spa therapies with advanced medical technology to achieve instant, lasting results.

Experience Vortex-Fusion

Each treatment uses a series of patented Best HydroPeel™ tips by Agape Medical Spa and Skin Care in Rhode Island and Massachusetts.  – each one has multiple abrasive edges to exfoliate the skin several times each pass, achieving better, more even results.

The unique spiral design creates a vortex effect to easily dislodge and remove impurities while simultaneously introducing hydrating skin solutions and potent antioxidants.

KoCarbon Ag Silver with Carbon Layer Wound Dressing Case Study 2: Left Lateral Foot Wound

KoCarbon Ag Silver with Carbon Layer Wound Dressing Case Study 2: Left Lateral Foot Wound

Dr. Ming-Wei Wu, D.O., Board Certified General and Wound Surgeon

Patient Background

69M c respiratory failure, L LE peripheral artery disease, thyroid disease, COPD, dysphagia developed sudden onset of L lateral foot wound. 


Debridement was performed and KoCarbon Ag Silver with Carbon layer wound dressing treatment was iniated. 6 weeks after treatment, Kocarbon Ag was change to hydrocolloid treatment.


4 weeks after KoCarbon Ag treatment, the wound was significantly reduced in size. At 6th week treated with KoCarbon Ag, the wound was largely improved

KoCarbon Ag Silver with Carbon Layer Dressing Case Study 2

Wound Dressing that changes color to alert nurses and doctors of infection in wounds

The color-changing dressing would eliminate the need to potentially slow healing and cause scarring by removing traditional dressings to test for the presence of bacteria. Photo by University of Bath
Testing for infection with burn patients can be slow and increases the risk for further infection. A wound dressing that reacts to infection by changing color could help slow antibiotic resistance and help doctors better treat burn patients, especially children, said researchers.

The color-changing dressing can tell the difference between harmless bacteria which live on the skin and infectious bacteria that pose a health risk to patients, according to study on trials with a prototype, published in Applied Materials and Interfaces.

Existing methods require dressings to be removed — a process painful for patients, which may result in slower healing and can cause long-term scars — and tests can take up to 48 hours.

The lengthy time frame, and difficulty in distinguishing between an infection and a cold, often leads doctors to prescribe antibiotics that are not necessary.

Affordable KoCarbon Ag Silver with carbon layer to absorb odor and toxic

“With current methods clinicians can’t tell whether a sick child might have a raised temperature due to a serious bacterial burn wound infection, or just from a simple cough or cold,” said Dr. Amber Young, clinical lead for the Healing Foundation Children’s Burns Research Center at Bristol Children’s Hospital, in a press release. “Being able to detect infection quickly and accurately with this wound dressing will make a real difference to the lives of thousands of young children by allowing doctors to provide the right care at the right time, and also, importantly, reduce the global threat of antibiotic resistance.”

The researchers designed a wound dressing using a hydrogel containing florescent dye that is released in the presence of pathogenic biofilms.

The dressings were tested with clinical strains of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Enterococcus faecalis, indicating the presence of a pathogen within about 4 hours. They were tested on a nanoporous polycarbonate membrane and using a porcine skin model of burn wound infection, finding the dressing to be responsive in both.

Next, Young said she will take samples from wounds and blisters to test the dressing’s response against real samples rather than pathogens cultured in the lab before moving toward a design for human trials.

“This new dressing technology will not only help clinicians provide the best possible treatment for patients with burns, but could also tell us a lot about how wound infections begin and how they affect the normal healing process,” said Dr. Brian Jones, a researcher at the University of Brighton. “This could in turn lead to even further advances in treating these infections.”

NanoSafe™ Coatings Establishing A Device Master File for Anti-microbials

NanoSafe™ Coatings Establishing A Device Master File for Anti-microbials

NanoSafe has patented an anti-microbial coating that can be permanently applied to metal, plastic and fabrics to provide bacterial and viral resistance

JUPITER, FL, USA, November 16, 2015 / — NanoSafe Coatings today announced the initiative to establish a Master Device File (MDF)with the FDA to insure that Medical Device companies seeking anti-microbial coating protection for medical products can expedite the 510(k) process. NanoSafe is an innovative leader with a patented technology that provides a non-leaching, permanent, non-super bug promoting coating that can be applied to metals, plastics and fabric that comprise medical devices.

The MDF will provide the FDA with validation aspects of the NanoSafe technology in the areas of:

• Formulation
• Manufacturing
• Antimicrobial Mechanism of Action
• Demonstration of Permanent binding
• Assessments of toxicity and leachables
• Biocompatibility
• Stability.

NanoSafe has developed a unique pilot program for companies to test the NanoSafe coating on medical devices called the NanoSafe CRADA, where-in a medical device or component can be sent for anti-microbial coating to the NanoSafe Contract Manufacturing facility and subsequently be tested for both bacterial and viral “killing” efficacy.

The CRADA also provides a Company with a Regulatory Assessment as to the viability and pathway required to combine the NanoSafe anti-microbial coating to a medical device and the testing pathways required under 510(k) guidelines. This Assessment will provide the key parameters of potentail anti-microbial product claims, device classifications, and testing required for a successful 510(k) filing and approval by the FDA.

It is well known that “Healthcare-associated infections (HAIs), many of which are caused by antibiotic-resistant bacteria, impact one in 25 patients in the United States each year. These preventable infections claim the lives
of 75,000 people and cost the healthcare industry between $36 billion and $45 billion annually.”

NanoSafe provides a viable alternative to heavy-metal applications for anti-microbial protection on medical devices to combat the causes of HAIs and welcomes Companies to initiate Pilot Studies with NanoSafe™.

KoCarbon Ag Silver Carbon Wound Dressing Case Study 1: Left Lateral Malleolus Pressure Ulcer by Equinox Medical

Dr. Ming-Wei Wu, D.O., Board Certified General and Wound Surgeon
Patient Background

65M c respiratory failure, dysphagia, CVA/intracranial hemorrhage, vegetative state, paraplegia, nonverbal, DM II, had sudden development of L lateral malleolus pressure ulcer.

Debridement was performed and KoCarbonAg® treatment was initiated.
4 weeks after treatment, KoCarbonAg® was change to hydrocolloid treatment.

Two weeks after KoCarbonAg treatment, the wound was clean and in proliferation phase.
At fourth week treated by KoCarbon Ag Silver with Carbon Wound Dressing, the wound was epithelialized mostly.


Electrical stimulation may offer alternative to antibiotics for wound treatment

For the first time, researchers have developed a way of using electrical stimulation in wound dressing that may offer an effective alternative to antibiotics. They found their approach nearly eliminated all of a multi-drug-resistant bacterium that is often found in infections that are hard to treat.
escaffold before and after
The e-scaffold reduced the bacterial population to 1/10,000th of its original size in 24 hours (before on the left, after on the right, scale rule is 50 µm).
Image credit: Washington State University

The team from Washington State University (WSU) in Pullman describes their electrochemical scaffold or “e-scaffold” approach to wound healing and how they tested it in the journal Scientific Reports.

They note that when they used the e-scaffold on a biofilm of the highly multi-drug-resistant Acinetobacter baumannii, it killed nearly all of the microbes within 24 hours. The bacterial population was reduced to 1/10,000th of its original size.

Also, when they tested the e-scaffold on pig tissue infected with A. baumannii, it killed most of the bacteria without damaging surrounding tissue.

A. baumannii is often implicated in difficult-to-treat biofilm infections on wound surfaces. If biofilms are not promptly removed from wounds, they can delay healing and chronic infection can set in.

Due to the rising problem of antibiotic resistance, there is an urgent need for alternatives. According to the Centers for Disease Control and Prevention (CDC), every year at least 2 million Americans become infected with antibiotic-resistant bacteria, and at least 23,000 of them die as a direct result of these infections.

Hydrogen peroxide attacks the biofilm

The idea of using electrical stimulation to treat infected wounds has been around for over 100 years, but experiments have been met with mixed results. One reason, suggests co-author Haluk Beyenal, a professor in chemical engineering and bioengineering, was a poor understanding about how electricity affects biological systems.

Prof. Beyenal says they are very excited by the progress they have made in this area:

“We have been doing fundamental research on this for many years, and finally, we are able to transfer it to technology.”

He and his colleagues discovered that applying electrical stimulation to biofilm reduces dissolved oxygen to hydrogen peroxide at the electrode surface.

Hydrogen peroxide is a disinfectant that attacks various essential cell components in bacteria and other microbes.

The team then developed the e-scaffold made of conductive carbon fabric. Running electrical current through the device – which acts as an electronic Band Aid – produces a low and constant concentration of hydrogen peroxide that kills bacteria.

The method works, says Prof. Beyenal, because of the way it controls the electrochemical reactions.

Other attempts to develop scaffolds for wound dressing have been met with mixed results. These have used a chemical approach – using antibacterial compounds like silver, zinc, iodine or honey, note the authors. But the problem with these is that they lose potency over time.

The e-scaffold appears to meet the need for continuous delivery of an antimicrobial effect at a constant concentration for a significant length of time. The authors conclude:

“This research establishes a novel foundation for an alternative antibiotic-free wound dressing to eliminate biofilms.”

The researchers have applied for a patent for the e-scaffold and plan to investigate its effects on other species of bacteria.

Scientists are exploring a variety of methods to address the rising problem of antibiotic resistance. For example, Medical News Today recently learned how the MRSA superbug might be defeated using a drug commonly used to treat breast cancer. A study in Nature Communications shows how tamoxifen – a drug used to treat hormone receptor-positive breast cancer – boosted the immune system to fight MRSA (methicillin-resistant Staphylococcus aureus) infection in mice.

Written by


Free Silver Carbon Wound Dressing Samples

Derma Sciences stock price decrease from $7 to $6

Derma Sciences (NASDAQ:DSCI) had its price target decreased by Piper Jaffray from $7.00 to $6.00 in a research report report published on Tuesday, Analyst Ratings reports. Piper Jaffray currently has a neutral rating on the stock.

In related news, insider Robert C. Cole bought 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 13th. The stock was acquired at an average price of $6.73 per share, for a total transaction of $33,650.00. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Bruce F. Wesson bought 10,000 shares of the business’s stock in a transaction that occurred on Thursday, August 13th. The shares were bought at an average price of $6.58 per share, with a total value of $65,800.00. The disclosure for this purchase can be found here.

Derma Sciences (NASDAQ:DSCI) traded up 2.52% during midday trading on Tuesday, reaching $5.70. The company’s stock had a trading volume of 112,519 shares. Derma Sciences has a 1-year low of $4.39 and a 1-year high of $9.89. The company’s market capitalization is $147.09 million. The company’s 50-day moving average price is $5.22 and its 200-day moving average price is $6.45.


Derma Sciences (NASDAQ:DSCI) last announced its earnings results on Monday, November 9th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.43) by $0.08. The business earned $22.20 million during the quarter, compared to analyst estimates of $22.31 million. On average, analysts predict that Derma Sciences will post ($1.68) earnings per share for the current fiscal year.

DSCI has been the topic of several other reports. Canaccord Genuity restated a buy rating and set a $18.00 price objective on shares of Derma Sciences in a research note on Monday, August 10th. Oppenheimer reissued a buy rating on shares of Derma Sciences in a research note on Wednesday, August 12th. Finally, Roth Capital restated a buy rating on shares of Derma Sciences in a report on Thursday, August 13th.

Derma Sciences, Inc. (NASDAQ:DSCI) is a tissue regeneration business, which is participated in the research and management of acute and chronic wounds, and burns. The business operates through three segments: pharmaceutical wound care, advanced wound care and wound care products that are traditional. Pharmaceutical wound care products consist of DSC127, a product for treating a number of dermal uses, including scar prevention and diabetic foot ulcers. DSC127 is in pre-clinical stage of scar prevention and in Phase III. Advanced wound care products include differentiated dressings, bandages and ointments for wound healing or prevent disease, including AMNIOEXCEL, TCC EZ, MEDIHONEY and AMNIOMATRIX, XTRASORB and BIOGUARD. Wound care products that are conventional include skin care products, ointments, gauze bandages, adhesive bandages, wound strips that are closer, catheter fasteners and commodity associated dressings.

durable medical equipment provider npwt pump rental revenue share

Sign up now for our Durable Medical Equipment Provider NPWT Pump Rental Revenue Share Program

Best Vampire face lift in Rhode Island

What is Vampire Facelift? I’ve been hearing about this vampire face lift ever since I saw a post of Kim Kardashian’s bloodied face instagram photos.

In this anti-aging age, perhaps it’s unsurprising that vampires — ancient, but with forever-young skin — are a cultural obsession. We now have a cosmetic treatment to fill in wrinkles, plump up hollow cheeks and improve skin quality, texture and volume.

The Vampire Lift in(Rhode Island)  is not surgery, but an in-office procedure that entails having blood drawn from your arm, then spun in a centrifuge to separate out the platelets. The Platelet Rich Plasma is then injected into your face with the goal of stimulating new collagen production. This is a safe treatment that patients tolerate beautifully with little to no downtime!

Best Medical and Skin Care Spa In Rhode Island

Some patients prefer the idea of using their own blood rather than a neurotoxin or synthetic filler to rejuvenate their faces. What could be better than your own blood!
The procedure can correct early signs of aging like crow’s feet, loss of facial volume and under-eye hollows in a progressive, natural way and rejuvenate a person’s appearance in a subtle but distinct way.

Agape Medical Spa In Rhode Island

Platelet Rich Plasma Protein on cosmetic patients can last for more than a year — sometimes 18 to 24 months. Long term studies have not been done at this time.

This year, the “Vampire Face-Lift” has been promoted on “The Rachael Ray Show” and “The Doctors.” It has also gotten air time on more than a dozen news programs. The Vampire Lift  has been in use since 2009 and is now being used by Doctors nationwide.

Global Negative Pressure Wound Therapy in the US wound care market for 2015

1. Global Negative Pressure Wound Therapy – US Market 2015 Industry Size, Trail, Review, Trends, Growth, Share, Research and Analysis

2. This report provides top line data relating to the clinical trials .

3. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

4. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Visit Full Report Here:

5. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

6. The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.

7. The Report provides enrollment trends for the past five years.

8. Report provides latest news for the past three months.

US Negative Pressure Wound Therapy Market Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Download Free Sample Report Here:

Contact US:

Joel John
Suite #8138, 3422 SW 15 Street,
Deerfield Beach, Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803

talley medical venturi pump replacement Talley Medical Venturi NPWT replacement pump halo mini negative pressure wound therapy pump halo mini npwt pump 300 cc disposable canister